UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.47 -0.01 (-0.01%) GOLD FUTURES
2,323.70 -7.50 (-0.32%) DOW
38,868.56 +16.29 (+0.04%) Bitcoin GBP
50,463.59 +244.77 (+0.49%)
Dr. Reddy's Laboratories Limited (DRREDDY.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 1.05T |
| Enterprise value | 996.76B |
| Trailing P/E | 20.11 |
| Forward P/E | 20.62 |
| PEG ratio (5-yr expected) | 4.99 |
| Price/sales (ttm) | 3.87 |
| Price/book (mrq) | 3.92 |
| Enterprise value/revenue | 3.67 |
| Enterprise value/EBITDA | 11.74 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | 27.79% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 6,505.50 |
| 52-week low 3 | 4,383.40 |
| 50-day moving average 3 | 6,221.89 |
| 200-day moving average 3 | 5,793.12 |
Share statistics
| Avg vol (3-month) 3 | 13.63k |
| Avg vol (10-day) 3 | 12.04k |
| Shares outstanding 5 | 166.53M |
| Implied shares outstanding 6 | 166.53M |
| Float 8 | 119.75M |
| % held by insiders 1 | 8.30% |
| % held by institutions 1 | 67.05% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 40 |
| Forward annual dividend yield 4 | 0.63% |
| Trailing annual dividend rate 3 | 40.00 |
| Trailing annual dividend yield 3 | 0.63% |
| 5-year average dividend yield 4 | 0.62 |
| Payout ratio 4 | 12.77% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 11 Jul 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 28 Aug 2006 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 19.24% |
| Operating margin (ttm) | 24.74% |
Management effectiveness
| Return on assets (ttm) | 12.38% |
| Return on equity (ttm) | 21.39% |
Income statement
| Revenue (ttm) | 271.3B |
| Revenue per share (ttm) | 1,631.51 |
| Quarterly revenue growth (yoy) | 6.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 80.98B |
| Net income avi to common (ttm) | 52.21B |
| Diluted EPS (ttm) | 313.15 |
| Quarterly earnings growth (yoy) | 10.60% |
Balance sheet
| Total cash (mrq) | 72.55B |
| Total cash per share (mrq) | 435.7 |
| Total debt (mrq) | 19.85B |
| Total debt/equity (mrq) | 7.41% |
| Current ratio (mrq) | 2.55 |
| Book value per share (mrq) | 1,608.58 |
Cash flow statement
| Operating cash flow (ttm) | 53.59B |
| Levered free cash flow (ttm) | 23.21B |
© 2024 Yahoo. All rights reserved.